在癌症疫苗的配方中利用刺激响应生物材料
Arun Kumar Singh1, Rishabha Malviya1, Bhupendra Prajapati2
1Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida 203201, India.
Journal of functional biomaterials
|May 26, 2023
概括
开发有效的癌症疫苗在输送和抗原选择方面面临挑战. 响应刺激的生物材料为改善癌症免疫疗法传递和疗效提供了一个有希望的解决方案.
科学领域:
- 免疫学 免疫学 免疫学
- 生物材料科学 生物材料科学
- 癌症研究 癌症研究
背景情况:
- 癌症疫苗旨在增强抗瘤免疫力,但落后于其他免疫疗法,如检查点封锁.
- 不充分的疫苗接种和抗原选择是阻碍临床成功的关键局限性.
- 最近的进展表明,在临床前和早期临床研究中,抗原特异性疫苗具有前途.
研究的目的:
- 审查用于癌症疫苗的刺激反应生物材料的当前发展.
- 突出这些生物材料在改善癌症免疫治疗交付和疗效方面的潜力.
- 讨论这个领域的挑战和未来的机会.
主要方法:
- 对用于癌症免疫治疗的刺激反应生物材料的当前研究进行分析.
- 审查加强疫苗输送和免疫反应调节的策略 in vivo.
- 确定生物材料基础癌症疫苗开发的挑战和未来方向.
主要成果:
- 响应刺激的生物材料正在成为克服癌症疫苗交付限制的关键策略.
- 这些材料可以通过调节免疫治疗的运输和分发来提高治疗效率和安全性.
- 有希望的临床前和早期临床数据支持使用具有先进传递系统的抗原特异性疫苗.
结论:
- 通过先进的生物材料优化癌症疫苗的输送对于临床成功至关重要.
- 响应刺激的生物材料代表了癌症免疫疗法的重大进步.
- 需要进一步的研究来应对挑战,并充分发挥这些创新方法的潜力.
更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.8K
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.3K
相关概念视频
Cancer Vaccines
447
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
447
Tumor Immunotherapy
584
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
584
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
